ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SRPT Sarepta Therapeutics Inc New

131.40
0.77 (0.59%)
Pre Market
Last Updated: 22:39:11
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.77 0.59% 131.40 22:39:11
Open Price Low Price High Price Close Price Previous Close
130.63
more quote information »

Recent News

Date Time Source Heading
02/5/202406:05BWSarepta Therapeutics Announces First Quarter 2024 Financial..
01/5/202408:38BWSarepta Therapeutics Announces Inducement Grants Under..
24/4/202422:30BWSarepta Therapeutics to Announce First Quarter 2024..
30/3/202407:00BWSarepta Therapeutics Announces Inducement Grants Under..
09/3/202409:38EDGAR2Form 144 - Report of proposed sale of securities
07/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:34EDGAR2Form 144 - Report of proposed sale of securities
05/3/202400:30BWSarepta Therapeutics to Present at Upcoming Investor..
02/3/202411:55EDGAR2Form 144 - Report of proposed sale of securities
02/3/202411:42EDGAR2Form 144 - Report of proposed sale of securities
02/3/202408:47EDGAR2Form 144 - Report of proposed sale of securities
01/3/202410:16BWSarepta Therapeutics Announces Inducement Grants Under..
01/3/202401:00BWSarepta Therapeutics Announces Call for Applications for the..
29/2/202408:05BWSarepta Therapeutics Announces Fourth Quarter and Full-Year..
22/2/202400:30BWSarepta Therapeutics to Announce Fourth Quarter and..
16/2/202423:00BWSarepta Therapeutics Announces U.S. FDA Acceptance of an..
14/2/202405:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/2/202410:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202410:29BWSarepta Therapeutics Announces Inducement Grants Under..
29/1/202423:00BWSarepta Therapeutics Announces Positive Data from Part B of..
17/1/202401:02BWSarepta Therapeutics Initiates Screening in EMERGENE, a..
09/1/202404:08EDGAR2Form 8-K - Current report
09/1/202403:55BWSarepta Therapeutics Reports Preliminary* Fourth Quarter and..
03/1/202400:30BWSarepta Therapeutics to Present at the 42nd Annual J.P...
30/12/202310:27BWSarepta Therapeutics Announces Inducement Grants Under..
23/12/202300:00BWSarepta Therapeutics Submits Efficacy Supplement to Expand..
06/12/202312:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202310:34BWSarepta Therapeutics Announces Inducement Grants Under..
21/11/202312:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202323:30BWSarepta Therapeutics to Present at the UBS Biopharma..
02/11/202307:05BWSarepta Therapeutics Announces Third Quarter 2023 Financial..
02/11/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202310:02BWSarepta Therapeutics Announces Inducement Grants Under..
31/10/202308:17DJNSarepta Therapeutics to Request Expansion of Elevidys to All..

Your Recent History

Delayed Upgrade Clock